Cargando…

A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening

Virtual screening (VS) is a well-established method in the initial stages of many drug and material design projects. VS is typically performed using structure-based approaches such as molecular docking, or various ligand-based approaches. Most docking tools were designed to be as global as possible,...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegel, Jacob, Senderowitz, Hanoch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744642/
https://www.ncbi.nlm.nih.gov/pubmed/35008467
http://dx.doi.org/10.3390/ijms23010043
_version_ 1784630156310085632
author Spiegel, Jacob
Senderowitz, Hanoch
author_facet Spiegel, Jacob
Senderowitz, Hanoch
author_sort Spiegel, Jacob
collection PubMed
description Virtual screening (VS) is a well-established method in the initial stages of many drug and material design projects. VS is typically performed using structure-based approaches such as molecular docking, or various ligand-based approaches. Most docking tools were designed to be as global as possible, and consequently only require knowledge on the 3D structure of the biotarget. In contrast, many ligand-based approaches (e.g., 3D-QSAR and pharmacophore) require prior development of project-specific predictive models. Depending on the type of model (e.g., classification or regression), predictive ability is typically evaluated using metrics of performance on either the training set ([Formula: see text]) or the test set (e.g., specificity, selectivity or [Formula: see text]). However, none of these metrics were developed with VS in mind, and consequently, their ability to reliably assess the performances of a model in the context of VS is at best limited. With this in mind we have recently reported the development of the enrichment optimization algorithm (EOA). EOA derives QSAR models in the form of multiple linear regression (MLR) equations for VS by optimizing an enrichment-based metric in the space of the descriptors. Here we present an improved version of the algorithm which better handles active compounds and which also takes into account information on inactive (either known inactive or decoy) compounds. We compared the improved EOA in small-scale VS experiments with three common docking tools, namely, Glide-SP, GOLD and AutoDock Vina, employing five molecular targets (acetylcholinesterase, human immunodeficiency virus type 1 protease, MAP kinase p38 alpha, urokinase-type plasminogen activator, and trypsin I). We found that EOA consistently outperformed all docking tools in terms of the area under the ROC curve (AUC) and EF(1%) metrics that measured the overall and initial success of the VS process, respectively. This was the case when the docking metrics were calculated based on a consensus approach and when they were calculated based on two different sets of single crystal structures. Finally, we propose that EOA could be combined with molecular docking to derive target-specific scoring functions.
format Online
Article
Text
id pubmed-8744642
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87446422022-01-11 A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening Spiegel, Jacob Senderowitz, Hanoch Int J Mol Sci Article Virtual screening (VS) is a well-established method in the initial stages of many drug and material design projects. VS is typically performed using structure-based approaches such as molecular docking, or various ligand-based approaches. Most docking tools were designed to be as global as possible, and consequently only require knowledge on the 3D structure of the biotarget. In contrast, many ligand-based approaches (e.g., 3D-QSAR and pharmacophore) require prior development of project-specific predictive models. Depending on the type of model (e.g., classification or regression), predictive ability is typically evaluated using metrics of performance on either the training set ([Formula: see text]) or the test set (e.g., specificity, selectivity or [Formula: see text]). However, none of these metrics were developed with VS in mind, and consequently, their ability to reliably assess the performances of a model in the context of VS is at best limited. With this in mind we have recently reported the development of the enrichment optimization algorithm (EOA). EOA derives QSAR models in the form of multiple linear regression (MLR) equations for VS by optimizing an enrichment-based metric in the space of the descriptors. Here we present an improved version of the algorithm which better handles active compounds and which also takes into account information on inactive (either known inactive or decoy) compounds. We compared the improved EOA in small-scale VS experiments with three common docking tools, namely, Glide-SP, GOLD and AutoDock Vina, employing five molecular targets (acetylcholinesterase, human immunodeficiency virus type 1 protease, MAP kinase p38 alpha, urokinase-type plasminogen activator, and trypsin I). We found that EOA consistently outperformed all docking tools in terms of the area under the ROC curve (AUC) and EF(1%) metrics that measured the overall and initial success of the VS process, respectively. This was the case when the docking metrics were calculated based on a consensus approach and when they were calculated based on two different sets of single crystal structures. Finally, we propose that EOA could be combined with molecular docking to derive target-specific scoring functions. MDPI 2021-12-21 /pmc/articles/PMC8744642/ /pubmed/35008467 http://dx.doi.org/10.3390/ijms23010043 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Spiegel, Jacob
Senderowitz, Hanoch
A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title_full A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title_fullStr A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title_full_unstemmed A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title_short A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
title_sort comparison between enrichment optimization algorithm (eoa)-based and docking-based virtual screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744642/
https://www.ncbi.nlm.nih.gov/pubmed/35008467
http://dx.doi.org/10.3390/ijms23010043
work_keys_str_mv AT spiegeljacob acomparisonbetweenenrichmentoptimizationalgorithmeoabasedanddockingbasedvirtualscreening
AT senderowitzhanoch acomparisonbetweenenrichmentoptimizationalgorithmeoabasedanddockingbasedvirtualscreening
AT spiegeljacob comparisonbetweenenrichmentoptimizationalgorithmeoabasedanddockingbasedvirtualscreening
AT senderowitzhanoch comparisonbetweenenrichmentoptimizationalgorithmeoabasedanddockingbasedvirtualscreening